G1 therapeutics to participate in td cowen's 5th annual oncology innovation summit

Research triangle park, n.c., may 22, 2024 (globe newswire) -- g1 therapeutics, inc. (nasdaq: gthx), a commercial-stage oncology company, today announced that g1's chief medical officer dr. raj malik and chief commercial officer andrew perry will participate in a fireside chat at td cowen's 5th annual oncology innovation summit: insights for asco & eha, on wednesday, may 29, at 8:30am edt.
COWN Ratings Summary
COWN Quant Ranking